Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,277) with videos related to
Page
of 128
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617
Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Human Molecular Genetics
|
July 17, 2014
The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease
Jason A Bonomo, Meijian Guan, Maggie C Y Ng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience
Raghava Kashyap, Ramin Alipour, Emma Boehm, et al.
JAMA
|
October 24, 2000
Comprehensive follow-up care and life-threatening illnesses among high-risk infants: A randomized controlled trial
R S Broyles, J E Tyson, E T Heyne, et al.
Bioconjugate Chemistry
|
December 15, 2016
Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α<sub>v</sub>β<sub>3</sub> Integrin Expression with Gallium-68
Cinzia Imberti, Samantha Y A Terry, Carleen Cullinane, et al.
BMC Genomics
|
August 12, 2008
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
L O Baumbusch, J Aarøe, F E Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2012
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
Elizabeth A Punnoose, Siminder Atwal, Weiqun Liu, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.
Brain : a Journal of Neurology
|
September 24, 2024
Plasma biomarkers in chronic single moderate-severe traumatic brain injury
Gershon Spitz, Amelia J Hicks, Stuart J McDonald, et al.
EJNMMI Physics
|
June 1, 2017
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program
Charline Lasnon, Elske Quak, Pierre-Yves Le Roux, et al.
Page
of 128
Search research articles
Search
Showing results (1041-1050 of 1,277) with videos related to
Sort By:
Page
of 128
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2020
Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617
Justin Ferdinandus, John Violet, Shahneen Sandhu, et al.
Human Molecular Genetics
|
July 17, 2014
The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease
Jason A Bonomo, Meijian Guan, Maggie C Y Ng, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 26, 2025
Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours - a single centre experience
Raghava Kashyap, Ramin Alipour, Emma Boehm, et al.
JAMA
|
October 24, 2000
Comprehensive follow-up care and life-threatening illnesses among high-risk infants: A randomized controlled trial
R S Broyles, J E Tyson, E T Heyne, et al.
Bioconjugate Chemistry
|
December 15, 2016
Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α<sub>v</sub>β<sub>3</sub> Integrin Expression with Gallium-68
Cinzia Imberti, Samantha Y A Terry, Carleen Cullinane, et al.
BMC Genomics
|
August 12, 2008
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
L O Baumbusch, J Aarøe, F E Johansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2012
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib
Elizabeth A Punnoose, Siminder Atwal, Weiqun Liu, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.
Brain : a Journal of Neurology
|
September 24, 2024
Plasma biomarkers in chronic single moderate-severe traumatic brain injury
Gershon Spitz, Amelia J Hicks, Stuart J McDonald, et al.
EJNMMI Physics
|
June 1, 2017
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program
Charline Lasnon, Elske Quak, Pierre-Yves Le Roux, et al.
Page
of 128